Assignee
SERENITY PHARMACEUTICALS LLC
US·5 granted patents·2 pending applications·8 citations·filing 2014–2021
Top patents by PatentIndex Score
7 records- 0189US11419914B2Safe desmopressin administrationSERENITY PHARMACEUTICALS LLC·Filed 2017·Granted Aug 23, 2022·3 cites·19 claims
- 0283US9814753B2Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonistSERENITY PHARMACEUTICALS LLC·Filed 2014·Granted Nov 14, 2017·3 cites·16 claims
- 0371US2022126039A1Intranasal desmopressin administrationSERENITY PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 0469US9925232B2Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitorSERENITY PHARMACEUTICALS LLC·Filed 2014·Granted Mar 27, 2018·2 cites·17 claims
- 0562US10568927B2Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonistSERENITY PHARMACEUTICALS LLC·Filed 2017·Granted Feb 25, 2020·0 cites·22 claims
- 0662US2020078542A1Intranasal desmopressin administrationSERENITY PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 0734US10286033B2Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonistSERENITY PHARMACEUTICALS LLC·Filed 2015·Granted May 14, 2019·0 cites·19 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →